Hansa Biopharma AB (publ) (FRA:24H)
Germany · Delayed Price · Currency is EUR 2.972
-0.094 (-3.07%)
At close: Dec 1, 2025
Hansa Biopharma AB Statistics
Total Valuation
FRA:24H has a market cap or net worth of EUR 307.78 million. The enterprise value is 368.98 million.
| Market Cap | 307.78M |
| Enterprise Value | 368.98M |
Important Dates
The next estimated earnings date is Thursday, February 5, 2026.
| Earnings Date | Feb 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 101.76M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +23.08% |
| Shares Change (QoQ) | +19.72% |
| Owned by Insiders (%) | 5.84% |
| Owned by Institutions (%) | 15.95% |
| Float | 56.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.05 |
| PB Ratio | -6.07 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.36 |
| EV / Sales | 22.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.11
| Current Ratio | 1.11 |
| Quick Ratio | 1.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.49 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -42.29% |
| Return on Invested Capital (ROIC) | -70.95% |
| Return on Capital Employed (ROCE) | -177.00% |
| Revenue Per Employee | 121,471 |
| Profits Per Employee | -436,026 |
| Employee Count | 135 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 26.30 |
Taxes
In the past 12 months, FRA:24H has paid 425,571 in taxes.
| Income Tax | 425,571 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.31% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +16.31% |
| 50-Day Moving Average | 2.93 |
| 200-Day Moving Average | 2.44 |
| Relative Strength Index (RSI) | 64.43 |
| Average Volume (20 Days) | 1,546 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:24H had revenue of EUR 16.16 million and -57.99 million in losses. Loss per share was -0.80.
| Revenue | 16.16M |
| Gross Profit | 9.61M |
| Operating Income | -51.46M |
| Pretax Income | -57.57M |
| Net Income | -57.99M |
| EBITDA | -51.25M |
| EBIT | -51.46M |
| Loss Per Share | -0.80 |
Balance Sheet
The company has 22.80 million in cash and 83.57 million in debt, giving a net cash position of -60.77 million.
| Cash & Cash Equivalents | 22.80M |
| Total Debt | 83.57M |
| Net Cash | -60.77M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -50.72M |
| Book Value Per Share | -0.60 |
| Working Capital | 4.02M |
Cash Flow
| Operating Cash Flow | -45.32M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 59.47% |
| Operating Margin | -318.53% |
| Pretax Margin | -356.32% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:24H does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.08% |
| Shareholder Yield | -23.08% |
| Earnings Yield | -18.84% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |